1.9万 件 ・ 関連度順
概要と使いどころ
Authenticate with the Openapi marketplace (oauth.openapi.com). Use when you need to create, inspect, renew or delete Bearer tokens, list available scopes, check wallet credit, subscriptions, or API usage stats. Required by every other openapi-* skill.
日本語の概要は準備中です。原文の説明を表示しています。
Save important context to persistent memory for future sessions. PROACTIVELY USE THIS when you detect: - Decisions: "let's go with", "decided to", "chose", "went with" - Learnings: "I learned", "turns out", "TIL", "realized", "discovered" - Errors resolved: "fixed", "the problem was", "solution was" - Client info: names, emails, phone numbers, addresses, invoice amounts - Preferences: "I prefer", "I like", "don't like", "always use" - References: API keys locations, file paths, URLs, credentials - Patterns: "pattern", "convention", "always do", "standard approach" - Important commands run worth remembering Do NOT ask permission - just capture silently when these patterns appear.
日本語の概要は準備中です。原文の説明を表示しています。
Audits actual components and routes against applicable WCAG 2.2 A/AA criteria using consumer-owned design-system evidence and repository tools. Use when asked for an accessibility audit, a11y check, keyboard or focus review, contrast check, or screen-reader verification.
日本語の概要は準備中です。原文の説明を表示しています。
Reviews page hierarchy, grouping, density, actions and state design using consumer-owned product and design-system guidance. Use when asked for a visual design review, page critique or whether a new page communicates its task clearly.
日本語の概要は準備中です。原文の説明を表示しています。
Analyze suspicious SMS/email messages, phishing links, redirects, domains, payloads, malware indicators, and suspected C2 infrastructure safely. Use when the user provides spam, smishing/phishing content, raw .eml headers, URLs, QR links, attachments, hashes, strange payloads, redirect chains, DNS/WHOIS/RDAP questions, C2 clues, exploit-chain questions, or asks what defenses to apply.
日本語の概要は準備中です。原文の説明を表示しています。
Authorized testing of LLM applications, agents, chatbots, RAG systems, guardrails, and tool-using model workflows. Use for LLM mode selection, jailbreak and prompt-injection assessment, guardrail bypass review, tool misuse, tool or system prompt disclosure, data exfiltration paths, model refusal/stop detection, bypass hypotheses, and hardening guidance.
日本語の概要は準備中です。原文の説明を表示しています。
Passive, citation-grounded review of security-relevant specifications, protocols, standards, APIs, and implementations. Use when a reviewer must trace external preconditions and invariants into source code without treating a cited claim as proof of a vulnerability.
日本語の概要は準備中です。原文の説明を表示しています。
Select established CTF and security-research tools for authorized artifact triage, web inspection, reversing, crypto, forensics, networking, and exploit validation. Use when a user provides a CTF-style tool catalog, asks which tools to use, or needs safe usage instructions for common offensive/security tools.
日本語の概要は準備中です。原文の説明を表示しています。
Safely develop, verify, and document proof-of-concept exploits and payloads for authorized targets inside isolated Workspace Containers. Use when a Hypothesis is well-founded, target authorization covers scope, and each active step will carry a durable approval — for minimal PoCs, impact verification, or reproducible exploit Evidence.
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive Mastra framework guide for building agents, workflows, tools, memory, workspaces, and storage with current APIs. Use for documentation lookup, API verification, TypeScript setup, common errors, migrations, and `mastra api` CLI tasks: inspect or call resources on local, Mastra platform, Trace Intelligence, or remote servers.
日本語の概要は準備中です。原文の説明を表示しています。
Pragmatic testing guidance focused on confidence, behavior over implementation details, and integration-first coverage. Use when designing a test strategy, writing or reviewing tests, reducing brittle mocks, or deciding what is worth testing in an application or library.
日本語の概要は準備中です。原文の説明を表示しています。
Expert in SQLite embedded database development for Tauri/desktop applications with focus on SQL injection prevention, migrations, FTS search, and secure data handling
日本語の概要は準備中です。原文の説明を表示しています。
Runnable end-to-end validation playbook for the Rembric TUI installer — catch breakage before merging/deploying, AND a sandboxed manual walkthrough to evaluate/iterate its UI/UX without polluting your real env. Apply before shipping any change touching `apps/plugin/install.sh`, the repo-root `install.sh` shim, any per-client `install.sh`/`uninstall.sh`, or distribution docs, or when you want to preview/try/demo the installer and polish how it looks and feels. Layered: CI-safe headless (vitest + `sh -n`), local install round-trips, operator interactive pty smoke, an optional full Docker `up` smoke, plus a sandboxed manual UX walkthrough. For the installer contract/what-not-to-break, see `rembric-tui-installer`.
日本語の概要は準備中です。原文の説明を表示しています。
End-to-end smoke against the local rembric dev server (`pnpm run dev`, host Next.js dev on :3000). Apply when the user says "smoke", "probar contra docker", "dev:up", or after applying an OpenSpec change that touches HTTP (`apps/web/src/app/api/`), MCP tools (`packages/mcp/src/`), or DB migrations (`packages/db/src/migrations/`). Encodes bring-up, readiness verification, probe pattern and teardown — not the probes themselves.
日本語の概要は準備中です。原文の説明を表示しています。
This skill recommends against initiating puberty blocking or gender-affirming hormone treatment in prepubertal children diagnosed with gender dysphoria or gender incongruence. Clinical triggers include a young child presenting with GD/gender incongruence and caregivers or clinicians considering hormone intervention.
日本語の概要は準備中です。原文の説明を表示しています。
This skill suggests using real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D). Trigger phrases include "Should I use RT-CGM+ADIP or MDI+SMBG for this T1D patient?" or "Is intensive pump therapy indicated for this patient?"
日本語の概要は準備中です。原文の説明を表示しています。
This skill indicates the need for periodic prolactin monitoring in transgender females undergoing estrogen therapy. Clinical triggers include a transgender female patient receiving estrogen treatment.
日本語の概要は準備中です。原文の説明を表示しています。
This skill determines whether testicular volume should be used as the primary or sole indicator of sexual development in male childhood cancer survivors who have received gonadotoxic treatments such as alkylating agents or testicular radiotherapy. Triggers include clinician questions like “Can I use testicular volume to assess puberty in this male survivor after chemotherapy?” or “Is testis size reliable for sexual maturity evaluation post‑radiation?”
日本語の概要は準備中です。原文の説明を表示しています。
Decide whether commonly-excluded patients (eating disorders, elderly ≥75, upper GI disease) can actually receive a GLP-1 receptor agonist. Use when a clinician asks "can I give semaglutide to a patient with binge eating disorder / anorexia / bulimia", "is liraglutide safe in an 80-year-old", "GLP-1 with GERD or chronic gastritis", "GLP-1 in sarcopenic elderly", or anytime a patient is being ruled out for GLP-1 therapy based on a perceived contraindication. Grounded in Gorgojo-Martínez 2023 §6 (Myths or Reality).
日本語の概要は準備中です。原文の説明を表示しています。
This skill suggests using real-time continuous glucose monitoring (CGM) rather than no CGM for outpatients with type 2 diabetes (T2D) who take insulin and/or sulfonylureas and are at high risk for hypoglycemia. It is triggered by clinician questions such as "Should I use CGM for this T2D patient on insulin or sulfonylureas with high hypoglycemia risk?" or "Is CGM indicated for this patient?"
日本語の概要は準備中です。原文の説明を表示しています。
This skill guides evaluation of venous thromboembolism (VTE) risk factors in Cushing's syndrome patients to prevent thrombotic complications. Use when assessing a CS patient for thrombotic risk, especially perioperatively; triggers include preoperative assessment, postoperative period (within 4-6 weeks), or presence of CS with additional risk factors such as prior VTE, immobilization, malignancy, or estrogen use.
日本語の概要は準備中です。原文の説明を表示しています。
Suggests CSII with good adherence to monitoring and dosing for adults with type 2 diabetes mellitus who have poor glycemic control despite intensive insulin therapy, oral agents, other injectable therapy, and lifestyle modifications. Trigger phrases include 'T2DM on multiple injectables still uncontrolled' and 'Consider pump for insulin-requiring T2DM failing other therapies'.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends early delivery based on individualized risk assessment rather than expectant management for pregnant patients with preexisting diabetes mellitus (PDM). Consider when evaluating delivery timing in the presence of diabetes‑related complications, suboptimal glycemia, abnormal fetal growth, or maternal comorbidities that may increase perinatal risk beyond 38 weeks gestation.
日本語の概要は準備中です。原文の説明を表示しています。
Evaluates basal insulin rates through basal rate testing across different time periods and adjusts as indicated. Triggered by clinician orders to 'Perform basal rate test to verify pump settings' or 'Check basal rates during periodic pump review'.
日本語の概要は準備中です。原文の説明を表示しています。